# TOPIRAMATE
> **ANDA215638** · Abbreviated New Drug Application (Generic) · Sponsor: XIAMEN LP PHARM CO · Approved 2024-11-05
## Drug
- **FDA Application Number:** ANDA215638
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOPIRAMATE
- **Generic name:** TOPIRAMATE
- **Active ingredients:** TOPIRAMATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** XIAMEN LP PHARM CO
- **Manufacturer:** Vitruvias Therapeutics, Inc.
- **First approval:** 2024-11-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215638)
---
*AI Analytics · CC0 1.0*